0001562555-25-000001.txt : 20250130 0001562555-25-000001.hdr.sgml : 20250130 20250129194143 ACCESSION NUMBER: 0001562555-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20250130 DATE AS OF CHANGE: 20250129 EFFECTIVENESS DATE: 20250130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ataraxa LP CENTRAL INDEX KEY: 0002053057 ORGANIZATION NAME: IRS NUMBER: 331389977 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-536778 FILM NUMBER: 25570722 BUSINESS ADDRESS: STREET 1: 817 BROADWAY STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 347-614-2682 MAIL ADDRESS: STREET 1: 817 BROADWAY STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0002053057 Ataraxa LP 817 BROADWAY 12TH FLOOR NEW YORK NY NEW YORK 10003 347-614-2682 DELAWARE None None Limited Partnership true 2024 n/a Ataraxa GP LLC 817 Broadway 12th Floor New York NY NEW YORK 10003 Executive Officer General Partner of Issuer n/a Avenir Management Company, LLC 817 Broadway 12th Floor New York NY NEW YORK 10003 Executive Officer Investment Manager of Issuer Andrew Sugrue 817 Broadway 12th Floor New York NY NEW YORK 10003 Promoter Manager of Issuer's General Partner and Investment Manager James Reynolds IV 817 Broadway 12th Floor New York NY NEW YORK 10003 Promoter Manager of Issuer's General Partner and Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false 2025-01-15 true true false 10000 Indefinite 1035000 Indefinite The reported amount sold and number of investors represent total contributions by all investors in the issue since inception. The current assets under management and current number of investors may be significantly different. false 8 0 0 0 The issuer's General Partner, Investment Manager (or an affiliate) is entitled to a management fee in an amount based on a percentage of assets and under management. false Ataraxa LP Christopher DeLuca Christopher DeLuca Authorized Person 2025-01-29